Ads
related to: huntington's disease
Search results
FDA lifts hold on PTC Huntington’s disease trial
BioPharma Dive via Yahoo Finance· 9 hours agoDive Brief: PTC Therapeutics said Thursday it can resume a Phase 2 trial of its Huntington’s disease drug in the U.S., following the ...
Decades of gene therapy research pay off big for Madison company
Wisconsin State Journal· 4 hours agoThirty years ago, when the idea that would give rise to Mirus Bio took shape in a UW-Madison...
From the Darién Gap to ‘The Great Dictator’
New York Times· 12 hours agoFor his latest art project, Javier Téllez makes eight Venezuelan migrants his collaborators on a film about power. Although his films and videos have...
People more likely to get dementia if their mother has Alzheimer's, study finds
Yahoo Life UK· 3 days agoAlzheimer’s is one of the most common forms of dementia, alongside Parkinson’s disease, Huntington’s...
Central Nebraska offers lots of choices for Father's Day weekend
Grand Island Independent· 6 days agoAlso on the schedule this weekend are the 10th annual Colossal Coney Contest; the second week of the...
Why Mt. Juliet's Del Webb neighbors will play pickleball for Alzheimer's: 'A crapshoot'
The Tennessean via Yahoo News· 2 days agoJoe Thompson, 85, is a Del Webb resident whose wife Marian Thompson, 81, was diagnosed about five...
The Perfect-Length Movie
The Atlantic· 4 days agoThis is an edition of The Atlantic Daily, a newsletter that guides you through the biggest stories of the day, helps you discover new ideas, and...
What's Going On: Local events calendar
Grand Island Independent· 5 days agoColossal Coney Contest, 10th annual, to benefit the Hargis House, 10:30 a.m., 104 E. Third St. (parking lot across the street). Father’s Day ice cream...
Neurocrine Biosciences Stock Tops Milestone Amid New Drug Plans
Investor's Business Daily· 6 days agoNeurocrine Biosciences continues to put up really healthy numbers, with an ostensible 335% profit...
Analysts Set Annexon, Inc. (NASDAQ:ANNX) Price Target at $15.33
ETF DAILY NEWS· 7 days agoShares of Annexon, Inc. (NASDAQ:ANNX – Get Free Report) have been given a consensus rating of “Buy” by the six research firms that are currently covering the firm, Marketbeat Ratings reports ...